Polymer-drug conjugate for osteoarthritis
Year
2019
Project team
Paula Hammond & Alan Grodzinsky with Brandon Johnston
Improving treatment to cartilage
Osteoarthritis affects 30 million Americans. However, there exists no drug that can slow disease progression. This project is developing a nanomaterial capable of targeted, sustained delivery of drugs to cartilage. By improving drug delivery to cartilage, the project aims to improve drug efficacy and create an osteoarthritis drug that can treat the underlying cause of the disease